IPO Announced
Seaport Therapeutics IPO
US$255m raised
Lodged 30 Apr 2026 · NASDAQ: SPTX · US$18.00 cash per share
Advisers
Lead managers
- Bookrunner
- Legal adviser
- Issuer
- Seaport Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Pharma
Similar deals
- Veradermics IPO Feb 2026 · US$256m · Dermatology
- Mentari Therapeutics placement May 2026 · US$290m · Biotech
- Avalyn Pharma IPO Apr 2026 · US$300m · Biotech
- Hemab Therapeutics Holdings IPO Apr 2026 · US$302m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
Sources
- May 2026 Latham Advises on Seaport Therapeutics Upsized Initial Public Offering lw.com
- 1 May 2026 Final IPO prospectus (424B4), Seaport Therapeutics, Inc. sec.gov
- 7 May 2026 Goodwin Advises Seaport Therapeutics on Pricing of $254.9 Million Upsized Initial Public Offering goodwinlaw.com





